{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T18:23:16Z","timestamp":1787250196624,"version":"build-2736575974"},"reference-count":73,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda??o para a Ci?ncia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BTM-MAT\/4738\/2020"],"award-info":[{"award-number":["PTDC\/BTM-MAT\/4738\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["ERC-StG-2019-848325"],"award-info":[{"award-number":["ERC-StG-2019-848325"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>To address the critical challenge of high-lethality pancreatic ductal adenocarcinoma and poor response to conventional chemotherapies, this study introduces a self-immolative micelle encapsulating paclitaxel (PTX) or gemcitabine (GEM), two frontline chemotherapeutic agents. These chemotherapeutic agents present a 2.3-fold reduction for GEM and a 61.7-fold reduction for PTX in IC50 values when conjugated to the micelle system, compared to their free drug counterparts. Through longitudinal bioluminescence imaging, we observed a significant reduction in peritoneal tumor implants versus metastatic tumor deposits growth and a decrease in metastatic spread in the GEM- and GEM+PTX-micelle (micelle@GEM and micelle@GEM+PTX)-treated groups compared with the free drug formulations. Gene expression analysis of treated tumors revealed interesting oncogenic pathways, including PI3K-Akt and MAPK signaling, suggesting a targeted action at the molecular level. Our results identified the dual roles of PSMA1 and UBE2C as poor prognostic markers of pancreatic cancer progression and as candidate genes of interest, with key roles in the ubiquitination and proteasome degradation pathways in the pathophysiology of the disease. These data suggest that encapsulation of PTX and GEM in these micelles embedded within a hydrogel could alter the pharmacokinetics and pharmacodynamics of these agents, thereby modulating their interactions with cellular targets. Such targeted approaches could transform the treatment of pancreatic cancer by providing tailored therapies based on the unique genomic landscape of an individual\u2019s tumor, thus optimizing the clinical outcomes.<\/jats:p>","DOI":"10.1021\/acsnanomed.5c00174","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:51:49Z","timestamp":1783453909000},"page":"1640-1658","source":"Crossref","is-referenced-by-count":0,"title":["<i>In Vivo<\/i>\n                    Multimodal Self-Immolative\nProdrug Nanomicelle-Hydrogel Modulate Key Intratumoral and Metastatic\nGenomic Signaling Pathways in Pancreatic Cancer"],"prefix":"10.1021","volume":"1","author":[{"given":"Joa\u0303o M. J. M.","family":"Ravasco","sequence":"first","affiliation":[{"name":"NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]},{"name":"NOVA Medical School|Faculdade de Cie\u0302ncias Me\u0301dicas, NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhenifer","family":"Oliveira","sequence":"additional","affiliation":[{"name":"NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]},{"name":"NOVA Medical School|Faculdade de Cie\u0302ncias Me\u0301dicas, NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joa\u0303o","family":"Conniot","sequence":"additional","affiliation":[{"name":"NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]},{"name":"NOVA Medical School|Faculdade de Cie\u0302ncias Me\u0301dicas, NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8630-1119","authenticated-orcid":true,"given":"Ba\u0301rbara B.","family":"Mendes","sequence":"additional","affiliation":[{"name":"NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]},{"name":"NOVA Medical School|Faculdade de Cie\u0302ncias Me\u0301dicas, NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Leal","sequence":"additional","affiliation":[{"name":"Universidade NOVA de Lisboa , , Campus de Caparica , ,","place":["Caparica, Portugal, 2829-516"]},{"name":"Instituto Polite\u0301cnico de Lisboa , , ,","place":["Lisboa, Portugal, 1549-020"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-6717","authenticated-orcid":true,"given":"Susete N.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Universidade NOVA de Lisboa , , Campus de Caparica , ,","place":["Caparica, Portugal, 2829-516"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-5948","authenticated-orcid":true,"given":"Carlos A. M.","family":"Afonso","sequence":"additional","affiliation":[{"name":"Universidade de Lisboa , , Av. Prof. Gama Pinto , ,","place":["Lisboa, Portugal, 1649-003"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8422-6792","authenticated-orcid":true,"given":"Joa\u0303o","family":"Conde","sequence":"additional","affiliation":[{"name":"NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]},{"name":"NOVA Medical School|Faculdade de Cie\u0302ncias Me\u0301dicas, NMS|FCM, Universidade NOVA de Lisboa , , ,","place":["Lisbon, Portugal, 1169-056"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"7","key":"2026082013062379000_cit1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic\ncancer epidemiology: understanding the role of lifestyle and inherited\nrisk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nature Reviews Gastroenterology\n& Hepatology"},{"key":"2026082013062379000_cit2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41591-023-02790-x","article-title":"Prospective\nobservational study on biomarkers of response in pancreatic ductal\nadenocarcinoma","volume":"30","author":"Jiang","year":"2024","journal-title":"Nature Medicine"},{"issue":"1","key":"2026082013062379000_cit3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology\nof Pancreatic Cancer:\nGlobal Trends, Etiology and Risk Factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World\nJournal of Oncology"},{"key":"2026082013062379000_cit4","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.3390\/cancers14102429","article-title":"Immunotherapy\nin Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune\nMicroenvironment, Predictive Biomarkers and Treatment Outcomes","volume":"14","author":"Di Federico","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"2026082013062379000_cit5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer Incidence, Mortality, Years of Life Lost Years\nLived With Disability, and Disability-Adjusted Life Years for 29 Cancer\nGroups From 2010 to 2019: A Systematic Analysis for the Global Burden\nof Disease Study 2019","volume":"8","author":"Global Burden of Disease 2019 Cancer Collaboration.","year":"2022","journal-title":"JAMA Oncology"},{"key":"2026082013062379000_cit6","volume-title":"Surveillance,\nEpidemiology, and End Results Program Cancer Stat Facts: Pancreatic\nCancer","year":"2022"},{"issue":"16","key":"2026082013062379000_cit7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1200\/JCO.2014.59.7625","article-title":"Progress\nin the Treatment of Metastatic Pancreatic Cancer and the Search for\nNext Opportunities","volume":"33","author":"Ko","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"2026082013062379000_cit8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic\ndevelopments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nature Reviews\nGastroenterology & Hepatology"},{"issue":"1","key":"2026082013062379000_cit9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/OP.22.00328","article-title":"Pancreatic Adenocarcinoma\nManagement","volume":"19","author":"Jiang","year":"2023","journal-title":"JCO Oncology Practice"},{"issue":"1","key":"2026082013062379000_cit10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13014-019-1345-6","article-title":"Pancreatic ductal adenocarcinoma:\nbiological hallmarks, current status, and future perspectives of combined\nmodality treatment approaches","volume":"14","author":"Orth","year":"2019","journal-title":"Radiation Oncology"},{"issue":"4","key":"2026082013062379000_cit11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s10147-023-02317-x","article-title":"Clinical\nPractice Guidelines for Pancreatic\nCancer 2022 from the Japan Pancreas Society: a synopsis","volume":"28","author":"Okusaka","year":"2023","journal-title":"International Journal of Clinical Oncology"},{"issue":"8","key":"2026082013062379000_cit12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer:\nadvances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"2026082013062379000_cit13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejca.2022.06.042","article-title":"Impact of first-line FOLFIRINOX versus Gemcitabine\/Nab-Paclitaxel\nchemotherapy on survival in advanced pancreatic cancer: Evidence from\nthe prospective international multicentre PURPLE pancreatic cancer\nregistry","volume":"174","author":"Santucci","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"2026082013062379000_cit14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41571-024-00896-w","article-title":"NALIRIFOX\nfor metastatic pancreatic adenocarcinoma:\nhope or hype?","volume":"21","author":"Nevala-Plagemann","year":"2024","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"10409","key":"2026082013062379000_cit15","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and\ngemcitabine in treatment-naive patients with metastatic pancreatic\nductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase\n3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"issue":"8","key":"2026082013062379000_cit16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nrgastro.2012.115","article-title":"The role of\nstroma in pancreatic\ncancer: diagnostic and therapeutic implications","volume":"9","author":"Erkan","year":"2012","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"2","key":"2026082013062379000_cit17","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","article-title":"Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment\nin Pancreatic Cancer","volume":"13","author":"Falcomata\u0300","year":"2023","journal-title":"Cancer Discovery"},{"issue":"25","key":"2026082013062379000_cit18","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine","volume":"363","author":"Kim","year":"2010","journal-title":"New England Journal\nof Medicine"},{"issue":"9","key":"2026082013062379000_cit19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.trecan.2021.05.001","article-title":"Nanomedicine-based\nstrategies to target and modulate the tumor microenvironment","volume":"7","author":"Mendes","year":"2021","journal-title":"Trends in Cancer"},{"issue":"9","key":"2026082013062379000_cit20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.trecan.2020.04.008","article-title":"Above and\nBeyond Cancer Therapy: Translating Biomaterials into the Clinic","volume":"6","author":"Conde","year":"2020","journal-title":"Trends in Cancer"},{"issue":"10018","key":"2026082013062379000_cit21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal\nirinotecan with fluorouracil\nand folinic acid in metastatic pancreatic cancer after previous gemcitabine-based\ntherapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial","volume":"387","author":"Wang-Gillam","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2026082013062379000_cit22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S2468-1253(19)30327-9","article-title":"Nab-paclitaxel plus gemcitabine in patients with locally\nadvanced pancreatic cancer (LAPACT): a multicentre, open-label phase\n2 study","volume":"5","author":"Philip","year":"2020","journal-title":"Lancet Gastroenterology & Hepatology"},{"key":"2026082013062379000_cit23","doi-asserted-by":"publisher","first-page":"104151","DOI":"10.1016\/j.ebiom.2022.104151","article-title":"Phase I study of intraperitoneal\naerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable\nperitoneal metastases","volume":"82","author":"Ceelen","year":"2022","journal-title":"eBioMedicine"},{"key":"2026082013062379000_cit24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ctrv.2019.06.005","article-title":"Checkpoint inhibitors\nin pancreatic cancer","volume":"78","author":"Henriksen","year":"2019","journal-title":"Cancer Treatment Reviews"},{"issue":"48","key":"2026082013062379000_cit25","doi-asserted-by":"publisher","first-page":"40733","DOI":"10.1021\/acsnano.5c14753","article-title":"Reprogramming Immunosuppressive Niches\nand the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen\nmRNA Plus Immune Adjuvant Nanocarrier Strategies","volume":"19","author":"Nel","year":"2025","journal-title":"ACS Nano"},{"issue":"7","key":"2026082013062379000_cit26","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/cas.15377","article-title":"Liposomal irinotecan (Onivyde): Exemplifying\nthe benefits of nanotherapeutic drugs","volume":"113","author":"Milano","year":"2022","journal-title":"Cancer\nScience"},{"issue":"38","key":"2026082013062379000_cit27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202507118","article-title":"Cascade-Targeted Nanoparticles for Enhanced Gemcitabine\nDelivery and Adenosine Metabolism Modulation to Overcome Treatment\nResistance in Pancreatic Cancer","volume":"12","author":"Fan","year":"2025","journal-title":"Advanced Science"},{"issue":"48","key":"2026082013062379000_cit28","doi-asserted-by":"publisher","first-page":"44605","DOI":"10.1021\/jacs.5c19387","article-title":"Thioketal-Incorporated Biodegradable\nLipid Nanoparticles Deliver mRNA to Ductal Epithelial Cells for Improved\nPancreatic Cancer Treatment","volume":"147","author":"Qiu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"2026082013062379000_cit29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41563-023-01472-w","article-title":"Hydrogels for RNA delivery","volume":"22","author":"Zhong","year":"2023","journal-title":"Nat. Mater."},{"issue":"2","key":"2026082013062379000_cit30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7150\/thno.22711","article-title":"Recent Advances\nin the Application\nof Vitamin E TPGS for Drug Delivery","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"issue":"2","key":"2026082013062379000_cit31","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ijpharm.2015.09.030","article-title":"Preparation of intravenous\ninjection\nnanoformulation of VESylated gemcitabine by co-assembly with TPGS\nand its anti-tumor activity in pancreatic tumor-bearing mice","volume":"495","author":"Xu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"2026082013062379000_cit32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2014.07.041","article-title":"Gemcitabine: Metabolism and molecular\nmechanisms of action, sensitivity and chemoresistance in pancreatic\ncancer","volume":"741","author":"de Sousa Cavalcante","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"2026082013062379000_cit33","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1021\/jm501371s","article-title":"Organic Carbamates\nin Drug Design and Medicinal Chemistry","volume":"58","author":"Ghosh","year":"2015","journal-title":"J. Med.\nChem."},{"issue":"2","key":"2026082013062379000_cit34","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1039\/C8NR04916E","article-title":"Nanoparticle heterogeneity: an emerging\nstructural parameter influencing particle fate in biological media?","volume":"11","author":"Rabanel","year":"2019","journal-title":"Nanoscale"},{"issue":"3","key":"2026082013062379000_cit35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s44222-022-00008-2","article-title":"Technological challenges\nof biomembrane-coated top-down cancer nanotherapy","volume":"1","author":"Ravasco","year":"2023","journal-title":"Nature Reviews Bioengineering"},{"issue":"1","key":"2026082013062379000_cit36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2008.08.006","article-title":"Glutathione:\nOverview of its protective\nroles, measurement, and biosynthesis","volume":"30","author":"Forman","year":"2009","journal-title":"Molecular\nAspects of Medicine"},{"issue":"11","key":"2026082013062379000_cit37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive\nnanocarriers for\ndrug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"issue":"33","key":"2026082013062379000_cit38","doi-asserted-by":"publisher","first-page":"17205","DOI":"10.1016\/S0021-9258(19)77815-6","article-title":"Glutathione\nmetabolism and its selective modification","volume":"263","author":"Meister","year":"1988","journal-title":"J.\nBiol. Chem."},{"issue":"11","key":"2026082013062379000_cit39","doi-asserted-by":"publisher","first-page":"16708","DOI":"10.1021\/acsami.5c02296","article-title":"Mapping\nTumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic\nCancer","volume":"17","author":"Kataki","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"2026082013062379000_cit40","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.21873\/invivo.12155","article-title":"The Effect of Gemcitabine on Cell Cycle Arrest and microRNA Signatures\nin Pancreatic Cancer Cells","volume":"34","author":"Daisuke","year":"2020","journal-title":"Vivo"},{"issue":"1","key":"2026082013062379000_cit41","doi-asserted-by":"publisher","first-page":"23490","DOI":"10.1038\/s41598-021-02503-9","article-title":"The effect\nof paclitaxel on apoptosis,\nautophagy and mitotic catastrophe in AGS cells","volume":"11","author":"Khing","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"2026082013062379000_cit42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3892\/ijo.2020.5053","article-title":"Inhibiting the NF-kappaB\npathway enhances the antitumor effect of cabazitaxel by downregulating\nBcl-2 in pancreatic cancer","volume":"57","author":"Li","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"6","key":"2026082013062379000_cit43","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41565-024-01673-7","article-title":"A large-scale machine learning analysis\nof inorganic nanoparticles in preclinical cancer research","volume":"19","author":"Mendes","year":"2024","journal-title":"Nat. Nanotechnol"},{"issue":"1\u20133","key":"2026082013062379000_cit44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0168-3659(01)00470-9","article-title":"Anticancer\ndrug delivery systems: multi-loaded N4-acyl poly(ethylene glycol)\nprodrugs of ara-C. II. Efficacy in ascites and solid tumors","volume":"79","author":"Choe","year":"2002","journal-title":"J. Controlled Release"},{"issue":"3","key":"2026082013062379000_cit45","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0039-6060(99)70099-1","article-title":"An orthotopic\nin vivo model of human pancreatic cancer","volume":"126","author":"Schwarz","year":"1999","journal-title":"Surgery"},{"issue":"5","key":"2026082013062379000_cit46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcsm.12225","article-title":"Establishment and characterization\nof a novel murine model of pancreatic cancer cachexia","volume":"8","author":"Michaelis","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"3","key":"2026082013062379000_cit47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","article-title":"Pancreatic\ncancer evolution and heterogeneity: integrating\nomics and clinical data","volume":"22","author":"Connor","year":"2022","journal-title":"Nature Reviews Cancer"},{"key":"2026082013062379000_cit48","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/bs.acr.2023.02.006","article-title":"Chapter Eight\n- Oncogenic signaling pathways in pancreatic ductal adenocarcinoma","volume-title":"Advances in Cancer Research","author":"Agrawal","year":"2023"},{"issue":"12","key":"2026082013062379000_cit49","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.trecan.2022.08.005","article-title":"Mechanisms of PDAC\nsubtype heterogeneity and therapy response","volume":"8","author":"Espinet","year":"2022","journal-title":"Trends in Cancer"},{"issue":"6","key":"2026082013062379000_cit50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","article-title":"AKT as a Therapeutic\nTarget for Cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"issue":"4","key":"2026082013062379000_cit51","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK Pathway in KRAS-Driven Tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"issue":"19","key":"2026082013062379000_cit52","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","article-title":"Proteogenomic characterization of pancreatic ductal\nadenocarcinoma","volume":"184","author":"Cao","year":"2021","journal-title":"Cell"},{"issue":"7592","key":"2026082013062379000_cit53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic\nanalyses identify molecular subtypes\nof pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"6","key":"2026082013062379000_cit54","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling\nand Disease: Beyond\nDiscovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"2026082013062379000_cit55","doi-asserted-by":"publisher","first-page":"101926","DOI":"10.1016\/j.ctrv.2019.101926","article-title":"New therapeutic targets in pancreatic cancer","volume":"81","author":"Lai","year":"2019","journal-title":"Cancer Treatment Reviews"},{"key":"2026082013062379000_cit56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-030-38266-7_4","article-title":"Proteostasis\nDysregulation in Pancreatic Cancer","volume-title":"Proteostasis\nand Disease: From Basic Mechanisms to Clinics","author":"Arpalahti","year":"2020"},{"issue":"1","key":"2026082013062379000_cit57","doi-asserted-by":"publisher","first-page":"166884","DOI":"10.1016\/j.bbadis.2023.166884","article-title":"Expanding\nthe ubiquitin code in pancreatic cancer","volume":"1870","author":"Yang","year":"2024","journal-title":"Biochimica\net Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"7806","key":"2026082013062379000_cit58","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","article-title":"Autophagy\npromotes immune\nevasion of pancreatic cancer by degrading MHC-I","volume":"581","author":"Yamamoto","year":"2020","journal-title":"Nature"},{"issue":"12","key":"2026082013062379000_cit59","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","article-title":"Towards a\nsystems understanding\nof MHC class I and MHC class II antigen presentation","volume":"11","author":"Neefjes","year":"2011","journal-title":"Nature Reviews Immunology"},{"issue":"8","key":"2026082013062379000_cit60","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1080\/15548627.2020.1769973","article-title":"Selective\nautophagy of MHC-I promotes immune evasion of pancreatic cancer","volume":"16","author":"Yamamoto","year":"2020","journal-title":"Autophagy"},{"issue":"18","key":"2026082013062379000_cit61","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1016\/j.cell.2021.07.020","article-title":"Targeting\nPin1 renders\npancreatic cancer eradicable by synergizing with immunochemotherapy","volume":"184","author":"Koikawa","year":"2021","journal-title":"Cell"},{"issue":"31","key":"2026082013062379000_cit62","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1002\/adma.201305683","article-title":"Advanced Materials\nand Nanotechnology for Drug Delivery","volume":"26","author":"Yan","year":"2014","journal-title":"Adv. Mater."},{"key":"2026082013062379000_cit63","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery:\nAn insight of the techniques for their characterization and assessment\nin biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J. Controlled Release"},{"issue":"1","key":"2026082013062379000_cit64","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","article-title":"The molecular biology\nof pancreatic adenocarcinoma:\ntranslational challenges and clinical perspectives","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"5","key":"2026082013062379000_cit65","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41575-019-0247-2","article-title":"Targeting\nhallmarks of cancer to enhance radiosensitivity in gastrointestinal\ncancers","volume":"17","author":"Buckley","year":"2020","journal-title":"Nature Reviews Gastroenterology &\nHepatology"},{"issue":"18","key":"2026082013062379000_cit66","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1093\/nar\/gkp596","article-title":"Transcriptome analysis\nby strand-specific sequencing of complementary DNA","volume":"37","author":"Parkhomchuk","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"2026082013062379000_cit67","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian\ntranscriptomes by RNA-Seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat. Methods"},{"issue":"7","key":"2026082013062379000_cit68","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts:\nan efficient general\npurpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"2026082013062379000_cit69","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated\nestimation of fold change\nand dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biology"},{"issue":"10","key":"2026082013062379000_cit70","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis\nfor sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biology"},{"issue":"1","key":"2026082013062379000_cit71","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR:\na Bioconductor package for\ndifferential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"2","key":"2026082013062379000_cit72","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/gb-2010-11-2-r14","article-title":"Gene ontology analysis\nfor RNA-seq: accounting for selection bias","volume":"11","author":"Young","year":"2010","journal-title":"Genome Biology"},{"issue":"1","key":"2026082013062379000_cit73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes\nand Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."}],"container-title":["ACS Nano Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnanomed.5c00174","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/anmafm\/article-pdf\/1\/7\/1640\/65813072\/acsnanomed.5c00174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/anmafm\/article-pdf\/1\/7\/1640\/65813072\/acsnanomed.5c00174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T17:23:15Z","timestamp":1787246595000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/anmafm\/article\/1\/7\/1640\/5202626\/In-Vivo-Multimodal-Self-Immolative-Prodrug"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,7]]},"published-print":{"date-parts":[[2026,8,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnanomed.5c00174","relation":{},"ISSN":["3067-5928"],"issn-type":[{"value":"3067-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]}}}